Table 3.
Development of CA groups in lmx1b.1/2 double morphants.
| MOlmx1b1/2 | MOlmx1b1/2 + MOp53 | |||
| 72hpf | 96hpf | 72 hpf | 96 hpf | |
| vDC group1 | reduced (36/36) | reduced (71/87) | reduced (10/31) | reduced (13/19) |
| vDC group3 | normal (36/36) | normal (87/87) | normal (31/31) | normal (19/19) |
| posterior vDC | dispersed (32/36) | dispersed (72/87) | dispersed (31/31) | dispersed (15/19) reduced (10/19) |
| PO | normal (36/36) | normal (87/87) | normal (31/31) | normal (19/19) |
| Pr | normal (36/36) | normal (87/87) | normal (31/31) | normal (19/19) |
| ACL | reduced (10/36) | normal (87/87) | normal (31/31) | reduced (7/19) |
| OB | reduced (14/36) | reduced(24/87) | normal (31/31) | normal (19/19) |
| LC | n.a. | n.a. | normal (31/31) | normal (19/19) |
| MO | reduced (34/36) | reduced (9/49) | reduced (6/31) | normal (19/19) |
| HB ectopic th | yes (22/36) | yes (20/49) | yes (5/31) | yes (3/19) |
The numbers in brackets represent the number of morphants that show the respective phenotypes and the total number of analyzed morphants. A visual estimate indicated an increase of th expressing cells in the LC of lmx1b.1/2 morphants, but unambiguous cell counting was not possible due to dense clustering of the cells. Abbreviations are as in Table 2. HB, hindbrain.